Our Company

The Boehringer Ingelheim Group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates globally with 143 affiliates and a total of more than 45,600 employees in 2016. The focus of the family-owned company, founded in 1885, is researching, developing, manufacturing and marketing new medications of high therapeutic value for human and veterinary medicine.

Social responsibility is an important element of the corporate culture at Boehringer Ingelheim. This includes worldwide involvement in social projects, such as the initiative “Making More Health” and caring for the employees. Respect, equal opportunities and reconciliation of work and family life form the foundation of the mutual cooperation. In everything it does, the company focuses on environmental protection and sustainability.

Financial Highlights

Amounts in millions of EUR,
unless otherwise indicated
2016 2015 Change
Net sales 15,850 14,798 +7%
by region
Europe 32% 28%
Americas 41% 47%
Asia, Australia, Africa 27% 25%
by business
Prescription Medicines 76% 76%
Consumer Health Care 10% 10%
Animal Health 9% 9%
Biopharmaceuticals 4% 4%
Industrial Customers and other sales 1% 1%
Research and development 3,112 3,004 +4%
Personnel expenses 4,570 4,518 +1%
Average number of employees 45,692 47,501 –4%
Operating income 2,872 2,269 +27%
Operating income as % of net sales 18.1% 15.3%
Group profit 1,853 1,577 +18%
as % of net sales 11.7% 10.7%
Group equity 11,327 9,603 +18%
Return on Group equity 19.3% 19.4%
Cash flow 2,484 2,605 –5%
Investments in tangible assets 645 591 +9%
Depreciation of tangible assets 516 475 +9%
FINANCIAL HIGHLIGHTS
PRODUCT PORTFOLIO